Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
La Revue De Medecine Interne|November 16, 2024
JAK inhibitors (JAKi): Mechanisms of action and perspectives in systemic and autoimmune diseasesLiticia Chikhoune, Claire Poggi, Julie Moreau, et al.The Journal of Organic Chemistry|October 25, 2011
Electrochemical synthesis and chemistry of chiral 1-cyanotetrahydroisoquinolines. An approach to the asymmetric syntheses of the alkaloid (-)-crispine a and its natural (+)-antipodeFadila Louafi, Julie Moreau, Saurabh Shahane, et al.La Revue De Medecine Interne|June 25, 2025
Safety profile of JAK inhibitors in inflammatory or autoimmune diseasesJulie Moreau, Liticia Chikhoune, Claire Poggi, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 10, 2021
Albumin/Creatinine Ratio for the Detection of Significant Proteinuria of Preeclampsia in Hospitalized Hypertensive WomenCamille Tourigny, Evelyne Rey, Julie Moreau, et al.Journal of Molecular Biology|July 21, 2009
Syncytin-2 plays an important role in the fusion of human trophoblast cellsAmandine Vargas, Julie Moreau, Sébastien Landry, et al.The Journal of Organic Chemistry|December 3, 2009
Metal-free Brønsted acid catalyzed formal [3 + 3] annulation. straightforward synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinonesJulie Moreau, Claudie Hubert, Jessika Batany, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|February 13, 2014
Rational design of a redox-labeled chiral target for an enantioselective aptamer-based electrochemical binding assayJulie Moreau, Lylian Challier, Noémie Lalaoui, et al.Cell Motility and the Cytoskeleton|July 1, 2009
Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeletonValérie Gagné, Julie Moreau, Mélodie Plourde, et al.Advances in Radiation Oncology|January 31, 2024
Dosimetric Evaluation and Reproducibility of Breath-hold Plans in Intensity Modulated Proton Therapy: An Initial Clinical ExperiencePouya Sabouri, Jason Molitoris, Maida Ranjbar, et al.La Revue De Medecine Interne|May 24, 2025
[Siltuximab as a salvage therapy in multi-refractory adult-onset Still's disease: A case series]Julie Moreau, Amélie Leurs, Emmanuel Ledoult, et al.Pageof 4